OpenVSafe by OpenVAERS
Search V-safe

5AG-15141-10769

3 vaccinations 3 coded responses 16 check-ins 3 free-text entries 0 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
335 / FL
Registered
2022-01-08
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-06
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-27
    Dose 2 — Pfizer-BioNTech
  3. 2022-01-08
    Registered in v-safe
  4. 2022-01-08
    Dose 3 — Pfizer-BioNTech
  5. 2022-01-08
    Health check-in — day 0, dose 3
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  6. 2022-01-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  7. 2022-01-10
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  8. 2022-01-11
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  9. 2022-01-12
    Survey response — days 1–6 daily, dose 3
    MedDRA: Oropharyngeal pain — Feeling: Good
    Free text: Sore throat
    MedDRA releases: 2024-11 · check-in free text available
  10. 2022-01-13
    Survey response — days 1–6 daily, dose 3
    MedDRA: Throat irritation — Feeling: Good
    Free text: Throat irritation
    MedDRA releases: 2024-11 · check-in free text available
  11. 2022-01-14
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  12. 2022-01-15
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  13. 2022-01-22
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  14. 2022-01-30
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  15. 2022-02-05
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  16. 2022-02-13
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  17. 2022-02-19
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  18. 2022-04-09
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  19. 2022-07-11
    Survey response — 6 months, dose 3
    MedDRA: Cough, Nasopharyngitis, Respiratory tract congestion — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Typical cold symptoms, congestion and cough.
    MedDRA releases: 2024-11 · check-in free text available
  20. 2023-01-08
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-06Pfizer-BioNTech No
22021-04-27Pfizer-BioNTech No
32022-01-08Pfizer-BioNTech No

Free text

Release 10 — days 1–6 daily, dose 3

2022-01-12

Systemic reaction (other): Sore throat

2022-01-13

Systemic reaction (other): Throat irritation

Release 12 — 6 months, dose 3

2022-07-11

Symptoms: Typical cold symptoms, congestion and cough.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDNasopharyngitis · · ✓
SDRespiratory tract congestion · · ✓
SROOropharyngeal pain · · ✓
SROThroat irritation · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release